Your browser doesn't support javascript.
loading
Implementing routine monitoring for nuclease contamination of equipment and consumables into the quality Management system of a laboratory.
Henry, Estelle; Charalambous, Eleftheria; Betsou, Fay; Mathieson, William.
Afiliação
  • Henry E; Integrated Biobank of Luxembourg, 1 rue Louis Rech, Dudelange, L-3555, Luxembourg.
  • Charalambous E; Integrated Biobank of Luxembourg, 1 rue Louis Rech, Dudelange, L-3555, Luxembourg.
  • Betsou F; Integrated Biobank of Luxembourg, 1 rue Louis Rech, Dudelange, L-3555, Luxembourg.
  • Mathieson W; Integrated Biobank of Luxembourg, 1 rue Louis Rech, Dudelange, L-3555, Luxembourg.
Heliyon ; 10(2): e24603, 2024 Jan 30.
Article em En | MEDLINE | ID: mdl-38298678
ABSTRACT
Nucleases are ubiquitous in the environment, present in biospecimens and widely used in many laboratory processes. However, in the wrong context, as contaminants, they have catastrophic potential because of their ability to rapidly degrade nucleic acids whilst retaining high resilience to inactivation. Although laboratories undertake rigorous precautions to prevent nuclease contamination, such measures are not infallible. In 2015, we devised and integrated a novel routine nuclease testing regimen into our Quality Management System that uses cleavable, fluorescent DNA and RNA substrates to detect, monitor and control for nuclease contamination in our laboratory processes, equipment and consumables. The testing regimen enables us to identify higher-risk activities, design our laboratory workflows such that risk is minimized and help fulfil our obligations in respect of ISO 203872018 General Requirements for Biobanking and ISO 17025 Testing and Calibrations Laboratory standards, both of which stipulate that environmental conditions in our laboratory must be monitored with defined quality control criteria. In seventeen rounds of testing (30 Test Items per round), 1.1 % of RNase tests and 0.2 % of DNase tests returned elevated nuclease levels (≥2.90 x 10-9 U RNase or 1.67 x 10-3 U DNase) and we were able to take remedial action. In no instance was an elevated nuclease level consequential in terms of an impact on sample quality. We present our protocols, results and observations.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Heliyon Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Luxemburgo

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Heliyon Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Luxemburgo